Clinical trial
Comparison of the Efficacy of Clarithromycin-based Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial
NCT01906879 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of Clarithromycin-based Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2013
- Completion date
- December 31, 2017
- Enrollment
- 1,620 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection